Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Patients With Relapsing-Remitting Multiple Sclerosis
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Biocad
- Target Recruit Count
- 24
- Registration Number
- NCT03551275
- Locations
- 🇷🇺
Institute of the Human Brain n. a. N.P. Bekhtereva Russian Academy of Sciences, Saint Petersburg, Russian Federation
🇷🇺Moscow Regional Research and Clinical Institute, Moscow, Russian Federation
🇷🇺Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russian Federation
Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- Biocad
- Target Recruit Count
- 75
- Registration Number
- NCT03519243
- Locations
- 🇷🇺
City Mariin Hospital, St. Petersburg, Russian Federation
🇧🇾City Clinical Hospital №9, Minsk, Belarus
🇷🇺B.Braun Avitum Russland Clinics Ltd., St.Petersburg, Russian Federation
Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Biocad
- Target Recruit Count
- 9
- Registration Number
- NCT03476993
- Locations
- 🇷🇺
State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
🇷🇺North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russian Federation
🇷🇺Smolensk state medical university, Smolensk, Russian Federation
Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Biocad
- Target Recruit Count
- 15
- Registration Number
- NCT03472027
- Locations
- 🇷🇺
N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg, Russian Federation
🇷🇺JSC "Modern Medical Technologies", Saint Petersburg, Russian Federation
🇷🇺N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation
A Study of BCD-135 in Patients With Advanced Solid Tumors
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Biocad
- Target Recruit Count
- 30
- Registration Number
- NCT03464032
- Locations
- 🇷🇺
LLC BioEk, Saint-Petersburg, Russian Federation
The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2021-11-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 105
- Registration Number
- NCT03455842
- Locations
- 🇷🇺
Chelyabinsk Regional Clinical hospital, Chelyabinsk, Russian Federation
🇷🇺North-Western State Medical University n.a. I.I.Mechnikov, Saint Petersburg, Russian Federation
🇷🇺Kazan State Medical University, Kazan, Russian Federation
International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis
- Conditions
- Interventions
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Biocad
- Target Recruit Count
- 228
- Registration Number
- NCT03447704
- Locations
- 🇷🇺
Non-governmental Healthcare Institution "Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways", Chelyabinsk, Russian Federation
🇷🇺LLC BioEk, Saint-Petersburg, Russian Federation
🇷🇺Kazan State Medical University, Kazan, Russian Federation
An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Biocad
- Target Recruit Count
- 213
- Registration Number
- NCT03390101
- Locations
- 🇷🇺
BIOCAD, Saint Petersburg, Strelna, Russian Federation
Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
- Conditions
- Interventions
- First Posted Date
- 2017-09-20
- Last Posted Date
- 2020-10-29
- Lead Sponsor
- Biocad
- Target Recruit Count
- 218
- Registration Number
- NCT03288870
- Locations
- 🇷🇺
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, Russian Federation
🇧🇾Gomel Regional Clinical Oncology Dispensary, Gomel, Belarus
🇷🇺N.N.Petrov Oncology Research Center, St.Petersburg, Russian Federation
International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma
- First Posted Date
- 2017-09-01
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 126
- Registration Number
- NCT03269565
- Locations
- 🇷🇺
State Budgetary Healthcare Institution "Moscow Clinical Scientific Center funded by Moscow Health Department" (SBHI MCSC MHD), Moscow, Russian Federation
🇷🇺"Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology)", Saint Petersburg, Russian Federation
🇷🇺LLC BioEk, Saint Petersburg, Russian Federation